(1)
Capmatinib in Patients With MET-Positive Advanced Non-Small Cell Lung Cancer: Analysis of the Russian Cohort in the Geometry Mono-1 Study. Вопр. онкол. 2022, 68 (6), 758-767. https://doi.org/10.37469/0507-3758-2022-68-6-758-767.